Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry.

Autor: Kennedy VE; University of California, San Francisco, CA., Perkins C; Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA., Reiter A; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Jawhar M; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Lübke J; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Kluin-Nelemans HC; University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Shomali W; Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA., Langford C; Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA., Abuel J; Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA., Hermine O; Imagine Institute Université de Paris, Sorbonne, INSERM U1163, Centre national de référence des mastocytoses, Hôpital Necker, Assistance publique hôpitaux de Paris, Paris, France., Niedoszytko M; Department of Allergology, Medical University of Gdansk, Gdańsk, Poland., Gorska A; Department of Allergology, Medical University of Gdansk, Gdańsk, Poland., Mital A; Department of Hematology, Medical University of Gdansk, Gdańsk, Poland., Bonadonna P; Department of Medicine, Section of Hematology, Verona University Hospital, Verona, Italy., Zanotti R; Department of Medicine, Section of Hematology, Verona University Hospital, Verona, Italy., Tanasi I; Department of Medicine, Section of Hematology, Verona University Hospital, Verona, Italy., Mattsson M; Department of Hematology, Uppsala University Hospital and Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Hagglund H; Department of Hematology, Uppsala University Hospital and Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Triggiani M; Division of Allergy and Clinical Immunology, University of Salerno, Salerno, Italy., Yavuz AS; Division of Hematology, Istanbul Medical School, University of Istanbul, Istanbul, Turkey., Panse J; Department of Oncology, Haematology, Haemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, and Center for Integrated Oncology, Aachen, Bonn, Cologne, Düsseldorf, Aachen, Germany., Christen D; Department of Oncology, Haematology, Haemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, and Center for Integrated Oncology, Aachen, Bonn, Cologne, Düsseldorf, Aachen, Germany., Heizmann M; Division of Oncology, Haematology and Transfusion Medicine, Kantonsspital Aarau AG, University Clinic of Medicine, Aarau, Switzerland., Shoumariyeh K; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg and German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany., Müller S; Department of Dermatology, Medical Center-University of Frieburg, Faculty of Medicine, University of Frieburg, Frieburg, Germany., Elena C; Hematology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Malcovati L; Hematology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Fiorelli N; Hematology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Wortmann F; Klinik für Hämatologie und Onkologie, Universitätsklinikum Schleswig-Holstein, Lübeck, Germany., Vucinic V; Universitätsklinikum Leipzig AöR, Leipzig, Germany., Brockow K; Department of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany., Fokoloros C; Mastocytosis Clinic, Allergy Unit, 2nd Department of Dermatology & Venereology, University of Athens, Attikon General University Hospital, Athens, Greece., Papageorgiou SG; Mastocytosis Clinic, Allergy Unit, 2nd Department of Dermatology & Venereology, University of Athens, Attikon General University Hospital, Athens, Greece.; 2nd Propaedeutic Department of Internal Medicine and Research Institute, Hematology Unit, University of Athens, Attikon University Hospital, Athens, Greece., Breynaert C; KU Leuven Department of Microbiology, Immunology, and Transplantation, Allergy and Clinical Immunology Research Group and MASTeL, University Hospitals Leuven, Leuven, Belgium., Bullens D; KU Leuven Department of Microbiology, Immunology, and Transplantation, Allergy and Clinical Immunology Research Group and MASTeL, University Hospitals Leuven, Leuven, Belgium., Doubek M; Brno University Hospital and Faculty of Medicine, Brno, Czechia., Ilerhaus A; Uniklinik Köln, Klinik für Dermatologie und Venerologie, Cologne, Germany., Angelova-Fischer I; Kepler University Hospital, Linz, Austria., Solomianyi O; Kepler University Hospital, Linz, Austria., Várkonyi J; Department of Hematology, Semmelweis University, Budapest, Hungary., Sabato V; Department of Immunology, Allergy, and Rheumatology, Universiteit Antwerpen, Campus Drie Eiken, Antwerp, Belgium., Rüfer A; Luzerner Kantonsspital, Lucerne, Switzerland., Schug TD; Univ.Klinik für Dermatologie, Medical University of Graz, Graz, Austria., Hermans MAW; Department of Internal Medicine, Section Allergy & Clinical Immunology, Erasmus Medical Center, Rotterdam, The Netherlands., Fortina AB; Pediatric Dermatology, Internal Medicine, Azienda Ospedaliera, Università di Padov, Padua, Italy., Caroppo F; Pediatric Dermatology, Internal Medicine, Azienda Ospedaliera, Università di Padov, Padua, Italy., Bumbea H; Department of Hematology, Carol Davila University of Medicine, Emergency University Hospital, Bucharest, Romania., Gulen T; Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, and Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Hartmann K; Division of Allergy, Departments of Dermatology and Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland., Elberink HO; University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Schwaab J; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Arock M; Laboratory of Hematology, Pitié-Salpêtrière Hospital, Paris, France., Valent P; Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Sperr WR; Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Gotlib J; Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA.

Publikováno v: Blood advances [Blood Adv] 2023 May 09; Vol. 7 (9), pp. 1713-1724.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Systemic Mastocytosis in a Patient with BCR-ABL1-Positive Chronic Myeloid Leukemia in the Remission Phase.

Autor: Fokoloros C; Allergy Unit 'D. Kalogeromitros', 2nd Department of Dermatology and Venereology, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Foukas P; 2nd Department of Pathology, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Georgakopoulos N; Department of Cytogenetics and Molecular Pathology, Locus Medicus S.A., Athens, Greece., Tsakiraki Z; 2nd Department of Pathology, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Bouchla A; Hematology Unit, 2nd Department of Internal Medicine, Propaedeutic, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Pappa V; Hematology Unit, 2nd Department of Internal Medicine, Propaedeutic, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Katoulis A; Allergy Unit 'D. Kalogeromitros', 2nd Department of Dermatology and Venereology, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Makris M; Allergy Unit 'D. Kalogeromitros', 2nd Department of Dermatology and Venereology, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Papageorgiou S; Department of Cytogenetics and Molecular Pathology, Locus Medicus S.A., Athens, Greece.

Publikováno v: Case reports in hematology [Case Rep Hematol] 2022 Nov 03; Vol. 2022, pp. 7251658. Date of Electronic Publication: 2022 Nov 03 (Print Publication: 2022).

Peroxisomal dysfunction interferes with odontogenesis and leads to developmentally delayed teeth and defects in distinct dental cells in Pex11b-deficient mice.

Autor: Colasante, Claudia¹ (AUTHOR) Claudia.Colasante@anatomie.med.uni-giessen.de, Jednakowski, Julia¹ (AUTHOR), Valerius, Klaus-Peter¹ (AUTHOR), Li, Xiaoling² (AUTHOR), Baumgart-Vogt, Eveline¹ (AUTHOR) Eveline.Baumgart-Vogt@anatomie.med.uni-giessen.de

Publikováno v: PLoS ONE. 12/9/2024, Vol. 19 Issue 12, p1-32. 32p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.